News and Updates

The FDA cleared the FreeStyle Libre 3 continuous glucose monitor (CGM) for children and adults ages 4 and up with diabetes

Breakthrough T1D has taken a bold new step to prevent and restore vision loss and blindness: Restoring Vision Moonshot, in honor of Mary Tyler Moore.

Breakthrough T1D has supported eye disease research since its beginning, and has driven discoveries that have reduced the risk of blindness by 95%.

Find out why we absolutely love psychologist Jill Weissberg-Benchell.

Leading researchers gathered, in person, for the annual meeting of the ATTD Conference (April 27-30), featuring 30+ studies presented by Breakthrough T1D scientists.

We're continuing that trend by putting the spotlight on video games and game developers with links to T1D.

Vertex provides an update on their Phase 1/2 Clinical Trial for VX-880, including data from three participants and details around the clinical hold.

Diabetes researchers from all over the world gather for the ATTD Conference, which will take place in-person and online from April 27-30 in Barcelona.

JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, has named two longtime, highly engaged volunteers to lead its International Board of Directors as Chair and Vice Chair, effective July 1, 2022.

You’ve seen the ads: Victoza®. Ozempic®. Trulicity®. But did you know that these drugs came about, in part, because of type 1 diabetes research?